首页> 外文OA文献 >PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease

【2h】

PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease

机译：头孢洛赞/他唑巴坦使用蒙特卡罗模拟对不同程度的肾功能包括增高的肾清除率和终末期肾脏疾病患者的PK / PD目标达成

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Alan J. Xiao; Luzelena Caro; Myra W. Popejoy; Jennifer A. Huntington; Ravina Kullar;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease [J] . Alan J. Xiao, Luzelena Caro, Myra W. Popejoy, Infectious Diseases and Therapy . 2017,第1期

机译：头孢洛赞/他唑巴坦使用蒙特卡罗模拟对不同程度的肾功能包括增高的肾脏清除率和终末期肾脏疾病患者的PK / PD目标达成
2. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? [J] . Mieke Carlier, Sofie Carrette, Jason A Roberts, Critical care : . 2013,第3期

机译：美罗培南和哌拉西林/他唑巴坦在危重患者中开处方：使用长时间输注时，增加的肾脏清除率是否会影响药代动力学/药效学目标的实现？
3. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? [J] . Mieke Carlier, Sofie Carrette, Jason A Roberts, Critical care : . 2013,第3期

机译：美罗培南和哌拉西林/他唑巴坦在危重患者中开处方：使用长时间输注时，增加的肾脏清除率是否会影响药代动力学/药效学目标的实现？
4. Total Renal Care Approach for Patients with End-Stage Renal Disease [C] . Yuka Kamijo, Shino Fujimoto, Yoshitaka Ishibashi Nihon To?seki Igakkai., Gakujutsu Shu?kai So?kai . 2018

机译：肾病患者肾脏护理方法
5. Is there an increased risk of cardiovascular disease in patients with functional adrenal incidentalomas vs. nonfunctional adrenal incidentalomas. [D] . Khan, Tooba Fatima. 2015

机译：功能性肾上腺偶发瘤与非功能性肾上腺偶发瘤患者心血管疾病的风险增加了吗？
6. PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function Including Augmented Renal Clearance and End-Stage Renal Disease [O] . Alan J. Xiao, Luzelena Caro, Myra W. Popejoy, 2017

机译：头孢洛赞/他唑巴坦使用蒙特卡罗模拟对不同程度的肾功能包括增高的肾清除率和终末期肾脏疾病患者的PK / PD目标达成
7. 403Ceftolozane/Tazobactam (C/T) Dose Optimization in Patients with End Stage Renal Disease (ESRD) Requiring Hemodialysis (HD) Using Population Pharmacokinetics (pPK) and Monte Carlo Simulations (MCS) [O] . Alan Xiao, Gurudatt Chandorkar, Gopal Krishna, 2014

机译：403Ceftolozane / TaZobactam（C / T）剂量优化在患有血液透析（HD）使用人口药代动力学（PPK）和蒙特卡罗模拟（MCS）的血液透析（HD）患者的剂量优化
8. Modified Augmented Renal Clearance Score Predicts Rapid Piperacillin and Tazobactam Clearance in Critically Ill Surgery and Trauma Patients. [R] . Akers, K. S., Niece, K. L., Chung, K. K., 2014

机译：改良的增强肾清除率预测危重手术和创伤患者的快速哌拉西林和他唑巴坦清除率。

PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease

著录项

相似文献

相关主题

期刊订阅